RRC ID 81511
著者 Keiichi Taniguchi, Takeshi Noshi, Shinya Omoto, Akihiko Sato, Takao Shishido, Keita Matsuno, Masatoshi Okamatsu, Scott Krauss, Richard J Webby, Yoshihiro Sakoda, Hiroshi Kida
タイトル The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir
ジャーナル Archives of Virology
Abstract Genetic reassortment of avian, swine, and human influenza A viruses (IAVs) poses potential pandemic risks. Surveillance is important for influenza pandemic preparedness, but the susceptibility of zoonotic IAVs to the cap-dependent endonuclease inhibitor baloxavir acid (BXA) has not been thoroughly researched. Although an amino acid substitution at position 38 in the polymerase acidic protein (PA/I38) in seasonal IAVs reduces BXA susceptibility, PA polymorphisms at position 38 are rarely seen in zoonotic IAVs. Here, we examined the impact of PA/I38 substitutions on the BXA susceptibility of recombinant A(H5N1) viruses. PA mutants that harbored I38T, F, and M were 48.2-, 24.0-, and 15.5-fold less susceptible, respectively, to BXA than wild-type A(H5N1) but were susceptible to the neuraminidase inhibitor oseltamivir acid and the RNA polymerase inhibitor favipiravir. PA mutants exhibited significantly impaired replicative fitness in Madin-Darby canine kidney cells at 24 h postinfection. In addition, in order to investigate new genetic markers for BXA susceptibility, we screened geographically and temporally distinct IAVs isolated worldwide from birds and pigs. The results showed that BXA exhibited antiviral activity against avian and swine viruses with similar levels to seasonal isolates. All viruses tested in the study lacked the PA/I38 substitution and were susceptible to BXA. Isolates harboring amino acid polymorphisms at positions 20, 24, and 37, which have been implicated in the binding of BXA to the PA endonuclease domain, were also susceptible to BXA. These results suggest that monitoring of the PA/I38 substitution in animal-derived influenza viruses is important for preparedness against zoonotic influenza virus outbreaks.
巻・号 169
公開日 2024-2-1
DOI 10.1007/s00705-023-05958-5
PMID 38216710
PMC PMC10786730
MeSH Amino Acid Substitution Animals Antiviral Agents / pharmacology Antiviral Agents / therapeutic use Dibenzothiepins* Dogs Drug Resistance, Viral / genetics Endonucleases / genetics Enzyme Inhibitors / pharmacology Enzyme Inhibitors / therapeutic use Humans Influenza A Virus, H5N1 Subtype* / genetics Influenza A virus* / genetics Influenza, Human* Morpholines* Orthomyxoviridae* / genetics Oxazines / pharmacology Pyridines / pharmacology Pyridines / therapeutic use Pyridones* Swine Thiepins* / pharmacology Thiepins* / therapeutic use Triazines*
IF 2.243
リソース情報
ヒト病原ウイルス Influenza A viruses (IAVs)